← All candidates
51 insider filings on record.
51 filings on record.
GRALGRAIL, Inc.
NasdaqGS · Healthcare · $3.35B
$75.11
-1.03% · Sep 16
51 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 22 sells◆ 6 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$3.35B
Float
34.3M
77% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
20.3
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
46 more transactions on Pro →Context
Wall St
$66.00 avg target
-12.1% vs today · 8 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26−$1.37 act+$0.59
Q4 '25−$2.44 act+$0.09
Q3 '25−$2.46 act+$0.81
Q2 '25−$3.18 act+$0.38
Coverage
Prediction: Grail Stock Will Skyrocket to $100 in 1 YearMotley Fool · 07-02A Blood Test That Screens for 50+ Cancers Just Moved Closer to Real-World Use. Here's What It Means for Grail Investors.Motley Fool · 06-21A Look At GRAIL (GRAL) Valuation After A Sharp One Day Share Price DropSimply Wall St. · 06-02Grail Plummets On Mixed Results For Cancer-Screening Blood TestInvestor's Business Daily · 06-01
The file stays open
51 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice